Release Date: 2023-09-14

Current Approach to Pulmonary Diseases in Diabetes Mellitus

Mihrican Yesildag (Author)

Release Date: 2023-09-14

Current approaches to managing pulmonary diseases in patients with diabetes mellitus involve comprehensive care strategies due to the complex interplay between these conditions. Diabetes mellitus increases the risk and severity of pulmonary complications such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia. Management focuses on controlling blood glucose levels to reduce the risk of [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page387
Last Page398
DOIhttps://doi.org/10.69860/nobel.9786053359111.36
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count12
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

Current approaches to managing pulmonary diseases in patients with diabetes mellitus involve comprehensive care strategies due to the complex interplay between these conditions. Diabetes mellitus increases the risk and severity of pulmonary complications such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia. Management focuses on controlling blood glucose levels to reduce the risk of exacerbations and complications. Additionally, optimizing respiratory health through smoking cessation, vaccination against respiratory infections, and regular pulmonary function testing are essential components of care. Collaborative efforts between endocrinologists, pulmonologists, and primary care providers are crucial in achieving optimal outcomes for these patients.

Mihrican Yesildag (Author)
MD, Konya Meram State Hospital
https://orcid.org/0000-0003-4198-810X

  • Braunwald E Kasper D, Fauci A, Hauser S, Longo D, Jameson J, et al. Harrison’s principles of internal medicine 15edition:2003: s: 2109-2143.

  • Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn Brussels, Belgium: International Diabetes Federation. 2015. Eur Respir J 2006; 27: 188-207.

  • Fujita T, Hemmi S, Kajiwara M, Yabuki M, Fuke Y, Satomura A, Soma M. Complement-mediated chronic infl ammation is associated with diabetic microvascular complication. Diabetes Metab Res Rev 2013. 29(3):220-226

  • Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus microand macrovascular complications: avenues for a mechanistic based therapeutic approach. Curr Diabetes Rev 2011. 7(5):313-324.

  • Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine 2007;176(6):532- 555.

  • Ferreira MA, Matheson MC, Duffy DL, Marks GB, Hui J, Le Souef P, Danoy P, Baltic S, Nyholt DR, Jenkins M, et al. Identifi cation of IL6R and chromosome 11q13.5 as risk loci for asthma. Australian Asthma Genetics Consortium. Lancet 2011. 378(9795):1006-1014

  • Fontaine-Delaruelle C, Viart-Ferber C, Luyton C, Couraud S. Lung function in patients with diabetes mellitus. Rev Pneumol Clin 2016. 72(1):10-16.

  • Vestbo J. Epidemiological studies in mucus hypersecretion. Novartis Found Symp 2002. 248:3-12.

  • McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 2001; 70:395-404.

  • Alfonso C, Han JO, Williams GS, Karlsson L. The impact of H2-DM on humoral immune responses. J Immunol 2001; 167:6348-55.

  • Michalkova D, Mikulecky M, Tibenska E. Alterations in lymphocyte subpopulations in peripheral blood at manifestation of type 1 diabetes mellitus in childhood. Bratisl Lek Listy 2000; 101: 365-70.

  • Kukreja A, Cost G Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, et all. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109:131-40.

  • Hayashi S., Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Tropical medicine & international health. TM & IH. 2018;23(10):1058–1070. https://doi.org.

  • Odone A, Houben RM, White RG, Lönnroth K. The effect of diabetes and under nutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014;2(9):754–764.

  • Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019;7(4): e448–e460.

  • Wang Ch, Yu CT, Lin HC, Liu CY, Kuo HP. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 1999; 79: 235- 42.

  • Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol. 2014;2(9):740–753.

  • Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001; 68: 595-600.

  • Cavalher-Machado SC, de Lima WT, Damazo AS, de Frias Carvalho V, Martins MA, e Silva PM, Sannomiya P. Downregulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J 2004; 24:552-8.

  • Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001; 68: 595-600.

  • Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001; 120:1435-7.

  • Jones TL, Neville DM, Chauhan AJ. Diagnosis and treatment of severe asthma: a phenotype-based approach. Clin Med (Lond) 2018. 18(Suppl 2): s36-s40.

  • Dandona P, Ghanim H, Monte SV, Caruana JA, Green K, Abuaysheh S, Lohano T, Schentag J, Dhindsa S, Chaudhuri A. Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring) 2014.

  • Thomsen SF, Duffy DL, Kyvik KO, Skytthe A, Backer V. Risk of asthma in adult twins with type 2 diabetes and increased body mass index. Allergy 2011. 66(4):562-568.

  • Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016. 9:1-12.

  • Yu H, Yang J, Xiao Q, Lü Y, Zhou X, Xia L, Nie D. Regulation of high glucose-mediated mucin expression by matrix metalloproteinase-9 in human airway epithelial cells. Exp Cell Res 2015. 333(1):127-135.

  • H. Kankaanranta, P. Kauppi, L. E. Tuomist, and P. Ilmarinen, “Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms,” Mediators of Infl ammation, vol. 2016, Article ID 3690628, 23 pages, 2016.

  • D. Yu and D. Simmons, “Association between lung capacity measurements and abnormal glucose metabolism: fi ndings from the Crossroads study,” Diabetic Medicine, vol. 31, no. 5, pp. 595–599, 2014.

  • Festa A, D’Agostino R Jr, Tracy RP, Haffner SM. Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002. 51(4):1131-1137.

  • Mulrennan S, Baltic S, Aggarwal S, Wood J, Miranda A, Frost F, Kaye J, Thompson PJ. The role of receptor for advanced glycation end products in airway infl ammation in CF and CF related diabetes. Sci Rep 2015. 5:8931.

  • Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP, Kanabar V, Matera MG. High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am J Respir Cell Mol Biol 2012. 47(4):509-516.

  • Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 2011. 105(4):519-525.

  • Akirav EM, Henegariu O, Preston-Hurlburt P, Schmidt AM, Clynes R, Herold KC. The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma. Plos One 2014. 9(4): e95678.

  • Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a crosssectional analysis of two cohorts. Lancet Respir Med 2016. 4(7):574-584.

  • Sindhu S, Koshy M, Al-Roub AA, Akhter N, Al Zanki S, Ali S, Devarajan S, Ahmad R. Differential association of plasma monocyte chemoattractant protein-1 withsystemic infl ammatory and airway remodeling biomarkers in type-2 diabetic patients with and without asthma. J Diabetes Metab Disord 2016. 15:40.

  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD, 2018.

  • Breyer MK, Spruit MA, Hanson CK, Franssen FM, Vanfl eteren LE, Groenen MT, Bruijnzeel PL, Wouters EF, Rutten EP. Prevalence of metabolic syndrome in COPD patients and its consequences. Plos One 2014. 9(6):e98013.

  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008. 32(4):962- 969.

  • Parappil A, Depczynski B, Collett P, Marks GB. Effect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPD. Respirology 2010. 15(6):918-922.

  • Bolton CE, Evans M, Ionescu AA, Edwards SM, Morris RH, Dunseath G, Luzio SD, Owens DR, Shale DJ. Insulin resistance and infl ammation- a further systemic complication of COPD. COPD. 2007;4(2):121– 126.

  • Obata Y, Yamada Y, Takahi Y, Baden MY, Saisho K, Tamba S, Yamamoto K, Umeda M, Furubayashi A, Matsuzawa Y. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocrinol (Oxf) 2013;79(2):204–210.

  • Franssen FM, O’Donnell DE, Goossens GH, Blaak EE, Schols AM. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63(12):1110–1117.

  • Khateeb J, Fuchs E, Khamaisi M. Diabetes and Lung Disease: An Underestimated Relationship. The Review Of Dıabetıc Studıes. Vol. 15 - 2019.

  • Rajasurya V, Gunasekaran K, Surani S. Interstitial Lung Disease and Diabetes.World J Diabetes 2020 August 15; 11(8): 351-35.

  • Forgiarini LA, Jr, Kretzmann NA, Porawski M, Dias AS, Marroni NA. Experimental diabetes mellitus: oxidative stress and changes in lung structure. J Bras Pneumol. 2009; 35:788–791.

  • Abernethy AD, Stackhouse K, Hart S, Devendra G, Bashore TM, Dweik R, Krasuski RA. Impact of diabetes in patients with pulmonary hypertension. Pulm Circ. 2015;5(1):117–123.

  • Arnold N, Koppula PR, Gul R, Luck C, Pulakat L. Regulation of cardiac expression of the diabetic marker microRNA miR-29. Plos One. 2014;9(7): e103284.

  • Lopez-Lopez JG, Moral-Sanz J, Frazziano G, Gomez-Villalobos MJ, Flores-Hernandez J, Monjaraz E, Cogolludo A, Perez-Vizcaino F. Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol. 2008;295(5): L727–L732.

  • Dewachter L, Dewachter C, Belhaj A. Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension. Eur Resp J. 2014; 44:58.

  • Karlin NJ, Amin SB, Buras MR, Kosiorek HE, Verona PM, Cook CB. Patient outcomes from lung cancer and diabetes mellitus: a matched case-control study. Future Sci OA. 2017;4(1): FSO248.

  • Xin WX, Fang L, Fang QL, Zheng XW, Ding HY, Huang P. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: a meta-analysis. Medicine (Baltimore) 2018;97(9): e0035.

  • Vicentini M, Ballotari P, Giorgi Rossi P, Venturelli F, Sacchettini C, Greci M, Mangone L, Pezzarossi A, Manicardi V. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: an observational population-based study. Diabetes Res Clin Pract. 2018; 143:398–408.

  • Jiang J, Ren HY, Geng GJ, Mi YJ, Liu Y, Li N, Yang SY, Shen DY. Oncogenic activity of insulin in the development of non-small cell lung carcinoma. Oncol Lett. 2018;15(1):447–452.

  • Reddy AT, Lakshmi SP, Reddy RC. PPARgamma as a novel therapeutic target in lung cancer. PPAR Res. 2016;2016: 8972570.]

  • Colice G, Price D, Gerhardsson de Verdier M, Rabon-Stith K, Ambrose C, Cappell K, Irwin DE, Juneau P, Vlahiotis A. The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship. Pragmat Obs Res. 2017; 8:231–240.

  • Wu Y, Liu HB, Shi XF, Song Y. Conventional hypoglycaemic agents and the risk of lung cancer in 59patients with diabetes: a meta-analysis. Plos One. 2014;9(6): e99577.

  • Romani-Perez M, Outeirino-Iglesias V, Gil-Lozano M, Gonzalez-Matias LC, Mallo F, Vigo E. Pulmonary GLP-1 receptor increases at birth and exogenous GLP-1 receptor agonists augmented surfactant-protein levels in litters from normal and nitrofen-treated pregnant rats. Endocrinology. 2013;154(3):1144–1155.

  • Han Y, Cho YE, Ayon R, Guo R, Youssef KD, Pan M, Dai A, Yuan JX, Makino A. SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery. Am J Physiol Lung Cell Mol Physiol. 2015;309(9): L1027–L1036.

  • Vale J, Manueal P, Oliveira E, Oliveira A, Silva E, Melo V, Sousa M, Alexandre J, Gil I, Sanchez A, Nascimento E, Torres A. Obstructive sleep apnea and diabetes mellitus. Rev Port Pneumol 2015; 21:55-60.

  • Ağan K, Sünter G, Aktaç Ş, Karadeniz D, Koşunda A, Aydın G, Fatma Güneş FE. Evaluation of the Relationship Between Obstructive Sleep Apnea Syndrome and Diabetes Mellitus in Terms of Anthropometric Measurements. Journal of Turkish

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!